MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Corcept Therapeutics Incorporated ROA 2011-2026 | CORT
ROA Jährlich Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.8 | 17.08 | 17.38 | 26.55 | 18.54 | 22.84 | 24.19 | 58.55 | 11.84 | -12.34 | -90.62 | -72.94 | -38.37 | -81.22 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 58.55 | -90.62 | -5.84 |
ROA Vierteljährlich Corcept Therapeutics Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.22 | 17.8 | 17.65 | 20.5 | 19.73 | 17.33 | 19.59 | 20.8 | 20.42 | 16.23 | 21.43 | 15.28 | 19.95 | 14.12 | 18.67 | 17.24 | 17.53 | 18.54 | 21.12 | 23.73 | 23.67 | 22.84 | 22.78 | 22.08 | 23.02 | 24.19 | 61.72 | 62.26 | 62.16 | 58.55 | 20.65 | 18.17 | 13.86 | 11.84 | 7.0 | 2.08 | -3.07 | -12.35 | -25.44 | -41.63 | -59.7 | -90.62 | -97.01 | -96.96 | -94.01 | -72.94 | -66.53 | -57.6 | -46.4 | -38.37 | -52.09 | -59.89 | -74.52 | -81.22 | -16.15 | -22.3 | -17.83 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 62.26 | -97.01 | -5.21 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M |  USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
-29.57 | $ 18.33 | -0.92 % | $ 2.7 B | USA |
 |
Amgen
AMGN
|
4.45 | $ 343.48 | 0.47 % | $ 184 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.12 | $ 72.81 | 5.02 % | $ 9.74 B | USA |
 |
I-Mab
IMAB
|
7.43 | - | - | $ 866 M |  China |
 |
Aytu BioScience
AYTU
|
-10.92 | $ 2.72 | 4.62 % | $ 17.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-37.44 | $ 2.99 | 8.55 % | $ 168 M | China |
 |
Biogen
BIIB
|
5.82 | $ 177.96 | -1.07 % | $ 25.9 B | USA |
 |
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M |  France |
 |
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.12 | -1.74 % | $ 7.51 B |  Australia |
 |
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | USA |
 |
Aptose Biosciences
APTO
|
-251.11 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-34.19 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
-21.48 | $ 1.4 | -0.71 % | $ 262 M | USA |
 |
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-35.36 | $ 223.74 | -1.05 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | USA |
 |
Burford Capital Limited
BUR
|
5.51 | $ 9.85 | 1.65 % | $ 1.59 B | Britain |
 |
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 4.13 | 2.92 % | $ 8.99 B |  Israel |
 |
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
65.02 | $ 110.82 | -2.58 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
-164.92 | - | - | $ 269 M | USA |
 |
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
-28.19 | $ 1.39 | 1.09 % | $ 355 M | Britain |
 |
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K | USA |
 |
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | USA |
 |
Cardiff Oncology
CRDF
|
-46.74 | $ 1.72 | -2.0 % | $ 82 M | USA |
 |
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-40.29 | - | -15.15 % | $ 60.3 M | Britain |
 |
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
-2.11 | $ 14.17 | 3.55 % | $ 4.38 B | USA |
 |
Compugen Ltd.
CGEN
|
-12.38 | $ 1.85 | 0.27 % | $ 166 M | Israel |
 |
AIkido Pharma
AIKI
|
-31.2 | - | 1.93 % | $ 17.4 M | USA |
 |
Atreca
BCEL
|
-62.67 | - | -11.76 % | $ 5.79 M | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
-18.12 | $ 6.68 | 1.52 % | $ 1.38 B | USA |
 |
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | USA |
 |
Beam Therapeutics
BEAM
|
-34.13 | $ 28.17 | 1.99 % | $ 2.32 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-10.89 | - | 0.49 % | $ 251 B |  Cayman-islands |